OpportunityTitle: Obstetric-Fetal Pharmacology Research Centers (OPRC) (U54)
AdditionalInformationOnEligibility: Other Eligible Applicants include the following:   Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.  Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.  Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Description: The purpose of this funding opportunity announcement (FOA) is to announce the competition of the Obstetric-Fetal Pharmacology Research Centers (OPRC) - a specialized cooperative multicenter program in the obstetric pharmacology research. The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) proposes to fund a limited number of research centers which will provide an arena for multidisciplinary interactions among basic and clinical scientists interested in establishing high quality translational research programs in the area of obstetric pharmacology. The centers will also serve as national resources for clinical pharmacological research in women during normal and abnormal pregnancies. Center investigators will be expected to work with NICHD staff in facilitating research collaborations and interactions within and among the centers. Such a cooperative program will form a national network that facilitates the translation of knowledge from the basic sciences into the development of new treatments, and findings from clinical studies/trials into practice with ultimate goal of improving the safety and effectiveness of the medical treatment in pregnant women.
GrantorContactEmailDescription: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
GrantorContactText: NIH OER Webmaster &lt;br/&gt;FBOWebmaster@OD.NIH.GOV &lt;br/&gt;